G

Genedrive PLC
LSE:GDR

Watchlist Manager
Genedrive PLC
LSE:GDR
Watchlist
Price: 1 GBX 14.29%
Market Cap: 10.3m GBX

GDR's latest stock split occurred on Sep 14, 2021

The company executed a 209-for-207 stock split, meaning that for every 207 shares held, investors received 209 new shares.

Before the split, GDR traded at 26.125 per share. Afterward, the share price was about 26.

The adjusted shares began trading on Sep 14, 2021. This was the only stock split in GDR's history.

Last Splits:
Sep 14, 2021
209-for-207
Pre-Split Price
25.875 26.125
Post-Split Price
26
Before
After
Last Splits:
Sep 14, 2021
209-for-207

Genedrive PLC
Stock Splits History

GDR Stock Splits Timeline
Sep 14, 2021
Sep 14, 2021
Split 209-for-207
x1.0096618357488
Pre-Split Price
25.875 26.125
Post-Split Price
26
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Jan 20, 2026
Linius Technologies Ltd
OTC:LNNTF
1-for-100
/100
0.0001 0.0001 USD N/A
Jan 20, 2026
Lotus Resources Ltd
OTC:LTSRF
1-for-11
/11
0.14 0.14 USD N/A
Jan 15, 2026
Amcor PLC
NYSE:AMCR
1-for-5
/5
8.46 8.46 USD N/A
Jan 8, 2026
Sumitomo Realty & Development Co Ltd
OTC:SURYY
2-for-1
x2
25.635 25.635 USD N/A
Dec 30, 2025
Adicet Bio Inc
NASDAQ:ACET
1-for-16
/16
0.4921 7.8736 USD 7.93 7.93 USD
Load More

Genedrive PLC
Glance View

Genedrive Plc is a holding company, which engages in the development of drugs and disease diagnostics. The Company’s Genedrive device is a molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Company’s commercial products include Genedrive MT-RNR1, Genedrive BioPlex, Genedrive HCV ID Kit and Genedrive 96 SARS-CoV-2 Ki. Genedrive MT-RNR1 is a commercial test for antibiotic induced hearing loss. Genedrive BioPlex is developed for the determination of military biothreats from pathogens. Genedrive HCV ID Kit is effective in the diagnosis of Hepatitis C Virus (HCV) infection in resource limited settings. Genedrive 96 SARS-CoV-2 Ki is a plate format of a COVID-19 molecular test for high throughput use, which detects all known variants of COVID-19.

GDR Intrinsic Value
0.37 GBX
Overvaluation 63%
Intrinsic Value
Price
G
Back to Top